Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children

Summary

Purpose of the study: • evaluate the efficacy and safety of Prospekta in the treatment of attention deficit/hyperactivity disorder in children.

Timeline

Start

2020-11-20

Primary completion

2022-02-18

Completion

2022-02-18

Outcome

Met primary endpoint

registry analysis (superiority test); Prospekta vs Placebo; p = 0.0199; Fisher Exact NCT04569357 ↗

Drugs

Indications